• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[一种预测膀胱癌治疗长期结果的综合方法]

[A complex approach to prediction of long-term results of urinary bladder cancer treatment].

作者信息

Zimichev A A, Prianichnikova M B, Maklakov V N

出版信息

Urologiia. 2010 May-Jun(3):47-9.

PMID:20734878
Abstract

Our investigations proved that the risk of bladder cancer relapse increases after organ-preserving treatment in exposure to exogenic and endogenic epidemiological factors. A significant deterioration of the prognosis as concerns a recurrence and lethal outcome risk is significantly related with some clinical and morphological characteristics of the tumor. The correlation-regression analysis has revealed a complex of the most significant independent factors which made a basis for a developed mathematic model of bladder cancer prognosis and a computer program for bladder cancer patients survival.

摘要

我们的研究证明，在接触外源性和内源性流行病学因素的情况下，保留器官治疗后膀胱癌复发的风险会增加。关于复发和致死结局风险的预后显著恶化与肿瘤的一些临床和形态学特征显著相关。相关回归分析揭示了一组最显著的独立因素，这些因素构成了所开发的膀胱癌预后数学模型和膀胱癌患者生存计算机程序的基础。

相似文献

1
[A complex approach to prediction of long-term results of urinary bladder cancer treatment].[一种预测膀胱癌治疗长期结果的综合方法]
Urologiia. 2010 May-Jun(3):47-9.
2
[Cancer of the urinary bladder: prognosis of the outcome].[膀胱癌：预后结果]
Urologiia. 2009 May-Jun(3):52-3.
3
[Cancer of the urinary bladder: prognosis of the course].[膀胱癌：病程预后]
Urologiia. 2009 Jul-Aug(4):48-51.
4
[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].[根治性膀胱切除术治疗浸润性膀胱癌的结果，特别提及根据尿流改道类型的预后因素和生活质量]
Ann Acad Med Stetin. 2000;46:217-29.
5
Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.综合保器官治疗后放疗膀胱浅表复发的管理
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1502-6. doi: 10.1016/j.ijrobp.2007.08.007. Epub 2007 Nov 1.
6
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.根据日本登记膀胱癌患者的数据得出的Ta、T1期非肌层浸润性膀胱癌肿瘤复发的临床结果：日本泌尿外科学会1999 - 2001年报告
Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.
7
Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients.初发T1G3期膀胱癌的膀胱保留治疗：多灶性、肿瘤大小或伴发原位癌是否重要？对132例患者的长期分析
Int J Urol. 2007 Nov;14(11):995-9; discussion 999. doi: 10.1111/j.1442-2042.2007.01890.x.
8
p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.p53和p21表达水平可预测采用综合治疗方法的浸润性膀胱癌的器官保留情况和生存率。
Cancer. 2004 May 1;100(9):1859-67. doi: 10.1002/cncr.20200.
9
Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.膀胱原发性浅表性移行细胞癌的预后因素：一项回顾性队列研究。
Chin Med J (Engl). 2006 Nov 5;119(21):1821-8.
10
Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.浸润性膀胱癌放射治疗为主的保留膀胱治疗的长期疗效
Urol Oncol. 2007 Jul-Aug;25(4):303-9. doi: 10.1016/j.urolonc.2006.09.015.